Results 211 to 220 of about 7,758 (250)

miR-33 inhibition as a novel therapeutic approach for treating muscular dystrophy. [PDF]

EMBO Mol Med
Lopez MA, Alexander MS.
europepmc   +1 more source

Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins. [PDF]

Medicina (Kaunas)
Luna-Angulo A, Landa-Solís C, Escobar-Cedillo RE, Estrada-Mena FJ, Sánchez-Chapul L, Gómez-Díaz B, Carrillo-Mora P, Avilés-Arnaut H, Jiménez-Hernández L, Jiménez-Hernández DA, Miranda-Duarte A.   +10 more
europepmc   +1 more source

The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy. [PDF]

Int J Mol Sci
Kiełbowski K, Bakinowska E, Procyk G, Ziętara M, Pawlik A.   +4 more
europepmc   +1 more source

Severe cardiac and skeletal manifestations in DMD-edited microminipigs: an advanced surrogate for Duchenne muscular dystrophy. [PDF]

Commun Biol
Otake M, Imamura M, Enya S, Kangawa A, Shibata M, Ozaki K, Kimura K, Ono E, Aoki Y.   +8 more
europepmc   +1 more source

Retention of stress susceptibility in the mdx mouse model of Duchenne muscular dystrophy after PGC-1α overexpression or ablation of IDO1 or CD38. [PDF]

Hum Mol Genet
Johnson EE, Southern WM, Doud B, Steiger B, Razzoli M, Bartolomucci A, Ervasti JM.   +6 more
europepmc   +1 more source

Two Novel Mouse Models of Duchenne Muscular Dystrophy with Similar Dmd Exon 51 Frameshift Mutations and Varied Phenotype Severity. [PDF]

Int J Mol Sci
Baikova IP, Ilchuk LA, Safonova PD, Varlamova EA, Okulova YD, Kubekina MV, Tvorogova AV, Dolmatova DM, Bakaeva ZV, Kislukhina EN, Lizunova NV, Bruter AV, Silaeva YY.   +12 more
europepmc   +1 more source

Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular Dystrophy. [PDF]

Antioxidants (Basel)
Abou-Samra M, Dubuisson N, Marino A, Selvais CM, Romain V, Davis-López de Carrizosa MA, Noel L, Beauloye C, Brichard SM, Horman S.   +9 more
europepmc   +1 more source

Utrophin in therapy of Duchenne muscular distrophy

, 2001
openaire   +2 more sources

Friend or Foe?: The Immune System's Dilemma With Dystrophin Replacement Therapy. [PDF]

JACC Basic Transl Sci
Townsend D.
europepmc   +1 more source

The Optic cup is actively shape programmed by independently patterned apical forces

Ramos AP, Moneta L, Szalapak A, Dagher L, Hillebrand M, Modes CD, Norden C.   +6 more
europepmc   +1 more source